A new cell line designated SQ-A was established from the spleen of a leukemic DBA/2J mouse inoculated with the anemic strain of Friend erythroleukemia virus (FLV-A). The cells are similar in morphology, growth pattern, and tumorigenicity to our prototype erythroleukemia line 5-86 but are more sensitive to the cytotoxic effects of inducers of differentiation. The virus produced by SQ-A cells induces erythroleukemia associated with anemia in adult mice but has little activity when assayed on XC cells. It was characterized to determine what factors influence its leukemogenic potential. As compared to the attenuated virus from cultures of 5-86 and G-2 cells, the subunits of the RNA from the virions of SQ-A cells are the same size, and the amount of reverse transcriptase activity and RNase H present in the purified virions of the three lines are similar. However, differences are observed in levels of endonuclease and protein kinase. Both enzymes are increased in SQ-A virions. The activity of protein kinase in SQ-A virions is about 5 times higher than that in the attenuated virions. The number of polypeptides and their phosphorylation patterns also distinguish the virions of SQ-A. Whereas 5-86 virions contain seven proteins, three of which are phosphorylated in vitro, SQ-A virions contain eight proteins, all of which are phosphorylated. The extra protein in SQ-A virions has a molecular weight of 25,000 and is not glycosylated.The lines of chronically infected murine erythroleukemia cells are widely used for studying the mechanism of gene expression and regulation of erythropoiesis because they can be stimulated to synthesize hemoglobin by treatment with dimethyl sulfoxide or any one of a number of other inducers that have the ability to switch on the program governing erythroid differentiation (1, 2). The cells of all lines developed in our laboratory produce substantial amounts of virus as estimated by the level of reverse transcriptase released into the culture fluid (3); however, the virus synthesized is attenuated (4). The reason for the loss of leukemogenicity of the virus after serial passage of the cells is not clear, nor is it known precisely what properties are required for the maintenance of virus pathogenicity. Our approach to the molecular pathology has been to develop new lines of leukemic cells and to follow the fate of the virus synthesized. We report here the establishment of one such line, designated SQ-A, which has been producing leukemogenic virus for several years. We have compared the properties of the cells and the virus produced to those of other Friend erythroleukemia virus (FLV)-transformed cells that synthesize attenuated virus. Thus far, the major differences between the leukemogenic virus synthesized by SQ-A cells and the attenuated virus of the other lines appear to be: (0) increased levels of endonuclease and protein kinase activity, (it) the presence of an extra polypeptide with a Mr of 25,000, and (iii) an increase in the number of peptides that become phosphorylated in vitro.
...